Shira Robbins, MD
Pediatric Ophthalmology and Strabismus Specialist · San Diego, CANPI 1508814914
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $3,000 of the $4,665 with a category attached, or 64.3%. Amgen accounts for 70.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2020 at $3,002 and has fallen 99.2% since, to $25 in 2022.
Across 22 payments — averaging $212.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- Neurocrine Biosciences, Inc.$1K
- Travere Therapeutics, Inc.$28
- Baxter Healthcare$14
Across 12 payments — averaging $3379.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch & Lomb Americas Inc.$33K
- Travere Therapeutics, Inc.$8K
What the payments were for
- Consulting fees$1,35029%
- Speaking & faculty fees$3,00064%
- Food & beverage$2796%
- Education$361%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 15 | $3,273 |
| Neurocrine Biosciences, Inc. | 1 | $1,350 |
| Travere Therapeutics, Inc. | 5 | $28 |
| Baxter Healthcare | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$3,000
How this compares
$4,665 in reported general payments places this provider in the 75th percentile of 28 pediatric ophthalmology and strabismus specialist providers in California.
See all pediatric ophthalmology and strabismus specialist providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pediatric ophthalmology and strabismus specialist in San Diego
- Mansoor MovagharSan Diego$319
- Jolene RudellSan Diego$235
- Scott McClatcheySan Diego$23
- Scott LambertPalo Alto$20K
- Donny SuhIrvine$14K
- Leila KhazaeniLoma Linda$9K
- Euna KooPalo Alto$6K
- Mark SilverbergSanta Barbara$5K
- Jennifer DunbarSan Bernardino$5K
- Mona FayadLos Angeles$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.